Table of Content

Table of Contents

1. Executive Summary

2. Global Gastroparesis Drug Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031
3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
3.2. Global Gastroparesis Drug Market Trends (2019-2024) and Forecast (2025-2031)
3.3: Global Gastroparesis Drug Market by Drug Class
3.3.1: Prokinetic Agents
3.3.2: Antiemetic Agents
3.3.3: Botulinum Toxin Injections
3.4: Global Gastroparesis Drug Market by Disease Type
3.4.1: Diabetic Gastroparesis
3.4.2: Idiopathic Gastroparesis
3.4.3: Post-surgical Gastroparesis
3.4.4: Others
3.5: Global Gastroparesis Drug Market by Distribution Channel
3.5.1: Hospitals
3.5.2: Pharmacies
3.5.3: Clinics
3.5.4: e-commerce

4. Market Trends and Forecast Analysis by Region from 2019 to 2031
4.1: Global Gastroparesis Drug Market by Region
4.2: North American Gastroparesis Drug Market
4.2.1: North American Market by Drug Class: Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections
4.2.2: North American Market by Disease Type: Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, and Others
4.3: European Gastroparesis Drug Market
4.3.1: European Market by Drug Class: Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections
4.3.2: European Market by Disease Type: Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, and Others
4.4: APAC Gastroparesis Drug Market
4.4.1: APAC Market by Drug Class: Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections
4.4.2: APAC Market by Disease Type: Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, and Others
4.5: ROW Gastroparesis Drug Market
4.5.1: ROW Market by Drug Class: Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections
4.5.2: ROW Market by Disease Type: Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, and Others

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Gastroparesis Drug Market by Drug Class
6.1.2: Growth Opportunities for the Global Gastroparesis Drug Market by Disease Type
6.1.3: Growth Opportunities for the Global Gastroparesis Drug Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Gastroparesis Drug Market by Region
6.2: Emerging Trends in the Global Gastroparesis Drug Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Gastroparesis Drug Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Gastroparesis Drug Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: Allergan
7.2: Abbott Laboratories
7.3: AstraZeneca
7.4: Cadila Pharmaceuticals
7.5: ETX Pharma
7.6: Evoke Pharma
7.7: GlaxoSmithKline